Pasit Phiasivongsa, Ph.D., has served as Executive Vice President, Technical Operations since February 2024 and previously as Senior Vice President, Technical Operations since August 2022. Prior to joining Nurix, Dr. Phiasivongsa served as Senior Vice President, Pharmaceutical Development & Manufacturing at Kronos Bio, where he led all CMC development, manufacturing, and supply chain-related activities. Before Kronos, Dr. Phiasivongsa served as Senior Vice President, Technical Operations at Principia Biopharma, where he incorporated key innovations into CMC development and manufacturing. Prior to Principia, he was Vice President, Pharmaceutical Development at Tobira Therapeutics, where he was responsible for CMC-related activities and led the intellectual property strategy and development for the company’s core assets. Early in his career, he held positions in drug discovery, development, and manufacturing. He is listed on 28 U.S.-issued patents and more than 30 patent applications. Dr. Phiasivongsa earned his B.S. in Biochemistry and Ph.D. in Pharmaceutical and Chemical Sciences from the University of the Pacific, Stockton.
'